| Literature DB >> 34166772 |
Yiyuan Xia1, Zhi-Hao Wang2, Zhentao Zhang2, Xia Liu3, Shan Ping Yu4, Jian-Zhi Wang5, Xiao-Chuan Wang6, Keqiang Ye7.
Abstract
Asparagine endopeptidase (AEP), a newly identified delta-secretase, simultaneously cleaves both APP and Tau, promoting Alzheimer's disease (AD) pathologies. However, its pathological role in AD remains incompletely understood. Here we show that delta-secretase cleaves BACE1, a rate-limiting protease in amyloid-β (Aβ) generation, escalating its enzymatic activity and enhancing senile plaques deposit in AD. Delta-secretase binds BACE1 and cuts it at N294 residue in an age-dependent manner and elevates its protease activity. The cleaved N-terminal motif is active even under neutral pH and associates with senile plaques in human AD brains. Subcellular fractionation reveals that delta-secretase and BACE1 reside in the endo-lysosomes. Interestingly, truncated BACE1 enzymatic domain (1-294) augments delta-secretase enzymatic activity and accelerates Aβ production, facilitating AD pathologies and cognitive impairments in APP/PS1 AD mouse model. Uncleavable BACE1 (N294A) inhibits delta-secretase activity and Aβ production and decreases AD pathologies in 5XFAD mice, ameliorating cognitive dysfunctions. Hence, delta- and beta- secretases' crosstalk aggravates each other's roles in AD pathogenesis.Entities:
Keywords: Alzheimer's disease; Aβ; Beta-secretase; Delta-secretase; Senile plaques
Mesh:
Substances:
Year: 2021 PMID: 34166772 PMCID: PMC8627568 DOI: 10.1016/j.pneurobio.2021.102113
Source DB: PubMed Journal: Prog Neurobiol ISSN: 0301-0082 Impact factor: 10.885